00:00PTPRODIA WIDIAHUSADA TBK
00:05PT PRODIA WIDIAHUSADA TBK informs about the plan to bring its business entity, PT PRODIA DIAGNOSTIC LINE, to the stock market.
00:14PRO LINE is prepared to carry out a public offering or initial public offering in the Indonesian stock market in the next 2-3 years.
00:23PT PRODIA WIDIAHUSADA TBK informs about the plan to bring its business entity, PT PRODIA DIAGNOSTIC LINE, to the stock market.
00:35From a number of business units, PRODIA GROUP, PRO LINE will be brought first for IPO.
00:41The management of Perseroan hopes that in a few years' time, PRO LINE will be more developed and ready to become an open company.
00:49PRO LINE is a business unit of PRODIA GROUP that operates in the diagnostic industry in vitro or IVD.
00:55Established since 2010, PRO LINE began production in 2012 with product portfolios such as Regen Chemiaclinic, Urine Strip, Molecular Products, Immunology, etc.
01:07PRODIA WIDIAHUSADA has acquired 39% of PT PRODIA DIAGNOSTIC LINE or PRO LINE shares in July 2024.
01:15In the same year, PRO LINE also built a new factory facility to increase its production capacity.
01:20The plan is that the factory will start operating in April 2025 with increased capacity up to three times the previous factory.
01:27PRODIA GROUP hopes that with the addition of PRO LINE's production capacity, it can support government programs in the health sector, such as free health checks.
01:36The company's management sees that the health industry has opportunities and open potential throughout the year.
01:42One of them is through a new government program that focuses on TDC monitoring and free health checks for 52.2 million Indonesians
01:53as a preventive measure against the potential risk of catastrophic diseases.
Comments